Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

A modulator based regulatory network for ERα signaling pathway.

Wu HY, Zheng P, Jiang G, Liu Y, Nephew KP, Huang TH, Li L.

BMC Genomics. 2012;13 Suppl 6:S6. doi: 10.1186/1471-2164-13-S6-S6.

2.

Hierarchical modularity in ERα transcriptional network is associated with distinct functions and implicates clinical outcomes.

Tang B, Hsu HK, Hsu PY, Bonneville R, Chen SS, Huang TH, Jin VX.

Sci Rep. 2012;2:875. doi: 10.1038/srep00875.

3.

Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.

Gu F, Hsu HK, Hsu PY, Wu J, Ma Y, Parvin J, Huang TH, Jin VX.

BMC Syst Biol. 2010 Dec 17;4:170. doi: 10.1186/1752-0509-4-170.

4.

A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer.

Shen C, Huang Y, Liu Y, Wang G, Zhao Y, Wang Z, Teng M, Wang Y, Flockhart DA, Skaar TC, Yan P, Nephew KP, Huang TH, Li L.

BMC Syst Biol. 2011 May 9;5:67. doi: 10.1186/1752-0509-5-67.

5.

Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.

Need EF, Selth LA, Harris TJ, Birrell SN, Tilley WD, Buchanan G.

Mol Endocrinol. 2012 Nov;26(11):1941-52. doi: 10.1210/me.2011-1314.

6.

Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.

Grober OM, Mutarelli M, Giurato G, Ravo M, Cicatiello L, De Filippo MR, Ferraro L, Nassa G, Papa MF, Paris O, Tarallo R, Luo S, Schroth GP, Benes V, Weisz A.

BMC Genomics. 2011 Jan 14;12:36. doi: 10.1186/1471-2164-12-36.

7.

Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.

Frietze S, O'Geen H, Littlepage LE, Simion C, Sweeney CA, Farnham PJ, Krig SR.

BMC Genomics. 2014 Jun 24;15:520. doi: 10.1186/1471-2164-15-520.

8.
9.

RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites.

Yamaga R, Ikeda K, Horie-Inoue K, Ouchi Y, Suzuki Y, Inoue S.

Horm Cancer. 2013 Aug;4(4):222-32. doi: 10.1007/s12672-013-0140-3.

PMID:
23526455
10.

Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.

Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.

J Cell Physiol. 2004 Sep;200(3):440-50.

PMID:
15254972
11.

A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.

Gajulapalli VN, Samanthapudi VS, Pulaganti M, Khumukcham SS, Malisetty VL, Guruprasad L, Chitta SK, Manavathi B.

Biochem J. 2016 Apr 15;473(8):1047-61. doi: 10.1042/BCJ20160019.

PMID:
26920025
12.

Unique ERalpha cistromes control cell type-specific gene regulation.

Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS, Brown M.

Mol Endocrinol. 2008 Nov;22(11):2393-406. doi: 10.1210/me.2008-0100.

13.

Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.

Tolhurst RS, Thomas RS, Kyle FJ, Patel H, Periyasamy M, Photiou A, Thiruchelvam PT, Lai CF, Al-Sabbagh M, Fisher RA, Barry S, Crnogorac-Jurcevic T, Martin LA, Dowsett M, Charles Coombes R, Kamalati T, Ali S, Buluwela L.

Breast Cancer Res Treat. 2011 Jul;128(2):357-68. doi: 10.1007/s10549-010-1122-6.

PMID:
20730598
14.

Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells.

Bourdeau V, Deschênes J, Laperrière D, Aid M, White JH, Mader S.

Nucleic Acids Res. 2008 Jan;36(1):76-93.

15.
16.

An integrated approach to characterize transcription factor and microRNA regulatory networks involved in Schwann cell response to peripheral nerve injury.

Chang LW, Viader A, Varghese N, Payton JE, Milbrandt J, Nagarajan R.

BMC Genomics. 2013 Feb 6;14:84. doi: 10.1186/1471-2164-14-84.

17.

Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations.

Nott SL, Huang Y, Li X, Fluharty BR, Qiu X, Welshons WV, Yeh S, Muyan M.

J Biol Chem. 2009 May 29;284(22):15277-88. doi: 10.1074/jbc.M900365200.

18.

Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei.

Ambrosino C, Tarallo R, Bamundo A, Cuomo D, Franci G, Nassa G, Paris O, Ravo M, Giovane A, Zambrano N, Lepikhova T, Jänne OA, Baumann M, Nyman TA, Cicatiello L, Weisz A.

Mol Cell Proteomics. 2010 Jun;9(6):1352-67. doi: 10.1074/mcp.M900519-MCP200.

19.

TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.

Woodfield GW, Horan AD, Chen Y, Weigel RJ.

Cancer Res. 2007 Sep 15;67(18):8439-43.

20.

Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.

Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J, Minden MD.

Mol Cancer Res. 2008 Aug;6(8):1347-55. doi: 10.1158/1541-7786.MCR-07-2179.

Items per page

Supplemental Content

Support Center